Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ratos is a Swedish publicly listed industrial holding company and active owner of Nordic small and mid-sized businesses, rather than a biotechnology, pharmaceutical, or healthcare operating company. The group focuses primarily on technological and infrastructure solutions across industry, construction and services, and consumer markets. While one of its subsidiaries, TFS HealthScience, operates as a global contract research organization serving biotech and pharma clients, Ratos itself is not a drug developer and does not have a therapeutic pipeline. Ratos develops and owns subsidiaries under their own brands and management teams and is listed on Nasdaq Stockholm. For biotech diligence purposes, Ratos is best classified as a diversified listed holding company with some exposure to life sciences services through portfolio holdings rather than as a pure-play healthcare company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ratos.